The global 3D printing drug market is projected to grow at a CAGR of 19% during the forecast period (2021-2027).
The global 3D printing drug market growth is driven by several factors such as increasing medical disability worldwide, increasing demand for cheap drugs or pills, and increasing adaptability of 3D printing in the healthcare industry. There is a growing awareness of the advantages of 3D printed drugs, such as instantaneous solubility. 3D printed drugs are very easy to swallow. These drugs are expected to grow in demand over the forecast period as these drugs can be customized to every patient’s requirements, supporting a better way than batch-produced drugs.
A full report of 3D Printed Drugs Market available at https://www.orionmarketreports.com/3d-printed-drugs-market/48402
Major Players:
• Aprecia Pharmaceuticals
• GlaxoSmithKline
• Revolution Medicines
• FabRX
3D Printed Drugs Market: Segmentation
By Technique type
• Roll Forming
• Stretch Forming
• Stamping
• Deep Drawing
• Hydroforming
• Others
By Application type
• BIW
• Chassis
• Closures
• Others
By Electric & Hybrid Vehicle type
• Fuel Cell Electric Vehicle (FCEV)
• Plug-in Hybrid Electric Vehicle (PHEV)
• Battery Electric Vehicle (BEV)
By ICE Vehicle type
• Passenger Car
• LCV
• Truck
• Bus
By Forming type
• Cold Forming
• Hot Forming
• Warm Forming
By Material type
• Steel
• Aluminum
• Magnesium
• Others
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
